$3.55 Billion is the total value of Casdin Capital, LLC's 53 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 20.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | $281,996,000 | -11.9% | 7,566,292 | 0.0% | 7.95% | -0.3% | |
| New | EQRX INC | $269,579,000 | – | 39,527,669 | +100.0% | 7.60% | – | |
| FATE | FATE THERAPEUTICS INC | $198,934,000 | -1.3% | 3,400,000 | 0.0% | 5.61% | +11.8% | |
| NVTA | INVITAE CORP | $186,350,000 | -46.3% | 12,203,669 | 0.0% | 5.25% | -39.2% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $169,580,000 | -10.2% | 1,000,000 | 0.0% | 4.78% | +1.7% | |
| BPMC | BLUEPRINT MEDICINES CORP | $166,021,000 | +4.2% | 1,550,000 | 0.0% | 4.68% | +17.9% | |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $163,489,000 | -19.9% | 7,990,652 | 0.0% | 4.61% | -9.3% | |
| EXAS | Sell | EXACT SCIENCES CORP | $158,773,000 | -29.5% | 2,040,000 | -13.6% | 4.48% | -20.2% |
| SOMALOGIC INC | $144,209,000 | -6.1% | 12,389,082 | 0.0% | 4.06% | +6.4% | ||
| MAXCYTE INC | $142,368,000 | -16.5% | 13,971,334 | 0.0% | 4.01% | -5.5% | ||
| CDXS | CODEXIS INC | $135,399,000 | +34.4% | 4,330,000 | 0.0% | 3.82% | +52.2% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $121,568,000 | +19.5% | 1,350,000 | +22.7% | 3.43% | +35.3% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $118,456,000 | +2.4% | 3,857,253 | +5.1% | 3.34% | +16.0% |
| VERV | Buy | VERVE THERAPEUTICS INC | $115,704,000 | -19.0% | 3,138,167 | +3.3% | 3.26% | -8.2% |
| GH | New | GUARDANT HEALTH INC | $79,016,000 | – | 790,000 | +100.0% | 2.23% | – |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $68,698,000 | -31.2% | 2,090,000 | -3.5% | 1.94% | -22.2% |
| TENAYA THERAPEUTICS INC | $67,970,000 | -8.2% | 3,586,818 | 0.0% | 1.92% | +3.9% | ||
| DNLI | Sell | DENALI THERAPEUTICS INC | $66,900,000 | -22.0% | 1,500,000 | -11.8% | 1.89% | -11.7% |
| BEAM | BEAM THERAPEUTICS INC | $65,252,000 | -8.4% | 818,820 | 0.0% | 1.84% | +3.7% | |
| ABSCI CORPORATION | $63,292,000 | -29.5% | 7,718,593 | 0.0% | 1.78% | -20.1% | ||
| TANGO THERAPEUTICS INC | $60,038,000 | -15.4% | 5,487,910 | 0.0% | 1.69% | -4.2% | ||
| RVMD | Sell | REVOLUTION MEDICINES INC | $59,653,000 | -22.6% | 2,370,000 | -15.4% | 1.68% | -12.3% |
| CDNA | Sell | CAREDX INC | $52,454,000 | -30.6% | 1,153,335 | -3.4% | 1.48% | -21.5% |
| TWST | Sell | TWIST BIOSCIENCE CORP | $51,851,000 | -51.5% | 670,000 | -33.0% | 1.46% | -45.1% |
| IPSC | CENTURY THERAPEUTICS INC | $50,853,000 | -37.0% | 3,206,380 | 0.0% | 1.43% | -28.6% | |
| BGNE | BEIGENE LTDsponsored adr | $40,640,000 | -25.4% | 150,000 | 0.0% | 1.14% | -15.5% | |
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $39,538,000 | -26.7% | 2,650,000 | +26.2% | 1.11% | -17.1% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $38,783,000 | -20.9% | 1,325,000 | -31.2% | 1.09% | -10.5% |
| Sell | GINKGO BIOWORKS HOLDINGS INC | $35,973,000 | -56.9% | 4,328,891 | -39.9% | 1.01% | -51.2% | |
| ALEC | ALECTOR INC | $34,073,000 | -9.5% | 1,650,000 | 0.0% | 0.96% | +2.5% | |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $28,060,000 | -42.7% | 1,000,000 | -30.6% | 0.79% | -35.1% |
| DERMTECH INC | $27,571,000 | -50.8% | 1,745,000 | 0.0% | 0.78% | -44.3% | ||
| New | SCIENCE 37 HOLDINGS INC | $22,446,000 | – | 1,800,000 | +100.0% | 0.63% | – | |
| SEMA4 HOLDINGS CORP | $22,300,000 | -41.2% | 5,000,000 | 0.0% | 0.63% | -33.4% | ||
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $20,190,000 | -32.3% | 266,430 | 0.0% | 0.57% | -23.3% | |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $19,621,000 | -8.3% | 960,882 | -0.0% | 0.55% | +3.8% |
| SEER | Buy | SEER INC | $18,248,000 | +252.3% | 800,000 | +433.3% | 0.51% | +298.4% |
| MGTA | MAGENTA THERAPEUTICS INC | $17,284,000 | -39.1% | 3,901,589 | 0.0% | 0.49% | -31.1% | |
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $16,680,000 | -44.6% | 1,442,870 | -46.4% | 0.47% | -37.3% |
| New | EXSCIENTIA PLCads | $14,107,000 | – | 713,900 | +100.0% | 0.40% | – | |
| ME | 23ANDME HOLDING CO | $12,264,000 | -26.5% | 1,841,457 | 0.0% | 0.35% | -16.6% | |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $12,187,000 | -59.5% | 555,455 | -50.2% | 0.34% | -54.2% |
| MASS | 908 DEVICES INC | $10,516,000 | -20.4% | 406,502 | 0.0% | 0.30% | -10.0% | |
| ZLAB | Sell | ZAI LAB LTDadr | $9,428,000 | -52.9% | 150,000 | -21.1% | 0.27% | -46.6% |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $9,390,000 | -25.6% | 548,156 | 0.0% | 0.26% | -15.6% | |
| GBIO | GENERATION BIO CO | $9,376,000 | -71.8% | 1,324,275 | 0.0% | 0.26% | -68.0% | |
| ORIC | ORIC PHARMACEUTICALS INC | $8,842,000 | -29.7% | 601,515 | 0.0% | 0.25% | -20.4% | |
| KRON | KRONOS BIO INC | $7,929,000 | -35.2% | 583,436 | 0.0% | 0.22% | -26.6% | |
| DBTX | DECIBEL THERAPEUTICS INC | $5,441,000 | -39.7% | 1,170,048 | 0.0% | 0.15% | -32.0% | |
| BLI | BERKELEY LTS INC | $3,636,000 | -7.1% | 200,000 | 0.0% | 0.10% | +5.2% | |
| STOK | STOKE THERAPEUTICS INC | $2,879,000 | -5.7% | 120,000 | 0.0% | 0.08% | +6.6% | |
| New | LIANBIOsponsored ads | $1,272,000 | – | 206,415 | +100.0% | 0.04% | – | |
| SANA | SANA BIOTECHNOLOGY INC | $929,000 | -31.2% | 60,000 | 0.0% | 0.03% | -23.5% | |
| NAUT | Exit | NAUTILUS BIOTECHNOLOGY INC | $0 | – | -225,000 | -100.0% | -0.03% | – |
| FHTX | Exit | FOGHORN THERAPEUTICS INC | $0 | – | -215,000 | -100.0% | -0.08% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -2,575,000 | -100.0% | -0.15% | – |
| TKNO | Exit | ALPHA TEKNOVA INC | $0 | – | -300,000 | -100.0% | -0.19% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -0.23% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -1,200,000 | -100.0% | -0.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 32 | Q3 2023 | 9.6% |
| ALNYLAM PHARMACEUTICALS INC | 32 | Q3 2023 | 9.9% |
| AGIOS PHARMACEUTICALS INC | 27 | Q2 2022 | 12.1% |
| GLOBAL BLOOD THERAPEUTICS IN | 27 | Q2 2022 | 7.1% |
| FATE THERAPEUTICS INC | 26 | Q3 2023 | 8.3% |
| BIOLIFE SOLUTIONS INC | 22 | Q3 2023 | 14.9% |
| CODEXIS INC | 22 | Q3 2023 | 8.1% |
| SAREPTA THERAPEUTICS INC | 21 | Q3 2023 | 13.6% |
| BLUEBIRD BIO INC | 21 | Q4 2020 | 7.8% |
| ILLUMINA INC | 21 | Q3 2023 | 6.0% |
View Casdin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Absci Corp | May 08, 2023 | 4,448,260 | 4.8% |
| CODEXIS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| DermTech, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Invitae Corp | February 14, 2023 | 9,038,388 | 3.7% |
| Magenta Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Tango Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Verve Therapeutics, Inc. | February 14, 2023 | 2,290,571 | 3.7% |
| Tenaya Therapeutics, Inc. | December 07, 2022 | 6,427,200 | 9.9% |
| Fulcrum Therapeutics, Inc. | February 11, 2021 | 1,241,176 | 4.5% |
| Gritstone Oncology, Inc.Sold out | February 11, 2021 | 0 | 0.0% |
View Casdin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-18 |
| SC 13D/A | 2024-04-08 |
| 4 | 2024-03-28 |
| 3 | 2024-03-25 |
| 4 | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 4 | 2024-03-06 |
| 4 | 2024-03-06 |
| 13F-HR | 2024-02-14 |
View Casdin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.